Advertisement
Advertisement
FATE
Fate Therapeutics, Inc.
2.33
USDSponsored
-0.10
-4.12%
Sep 24, 15:57 UTC -4
Closed
Pre-Market
2.37
+0.04
+1.72%
Fate Therapeutics, Inc. Financial Snapshot
| Market Cap | 283.97M |
| Beta | 2.54 |
| Earnings Per Share (EPS) | -1.05 |
| Price-to-Book (P/B) Ratio | 1.96 |
| Operating Margin | -1941.09% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -65.08% |
| Current Ratio | 4.85% |
| Free Cash Flow | -54.58M |
